Pulmonary surfactant based anticancer drug

Item Number: 630
Industry: Therapeutic
Category: Oncology, Respiratory Disease
Development Stage: Early Stage
Organisation Type: Government Institute
Country: South Korea
Patent: Korea
Business Opportunity: Out-Licensing, Technology Transfer, Collaboration R&D


The present invention relates to pulmonary surfactant based anticancer drugs which effectively target lung cancer cells, particularly adenocarcinomas derived from alveolar type II cells.

Features & Contact

Sign in and you'll be able to send enquiries about this item, view full details and save it